Jessica Niederee

DMD | Dentist



  
  4746 Belleview Ave, Kansas City
  Missouri, 64112

  816-531-8740    316-776-2980 Maps & Directions
Jessica Niederee is a Kansas City, Missouri based Dentist who is specialized in Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 4746 Belleview Ave, Kansas City. Patients can reach her at 816-531-8740.
Jessica Niederee is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Jessica Niederee speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Jessica Niederee
Specialization: Dentist
Gender:Female
Credentials: DMD
Accepts Medicare Assignment:May Accept
Practice Address:4746 Belleview Ave, Kansas City,
Missouri, 64112
Phone:816-531-8740
Fax:316-776-2980
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 9032436118
Enrollment ID: I20150330001529
NPI Number: 1508271834
NPI Enumeration Date: 25 Jun, 2014
NPI Last Update On: 15 May, 2018

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 4746 Belleview Ave,
Kansas City, Missouri
Zip: 64112-1315
Phone Number: 816-531-8740
Fax Number: 316-776-2980
Patients can reach Jessica Niederee at 4746 Belleview Ave, Kansas City, Missouri or can call to book an appointment on 816-531-8740. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: